Huajian Medical Holdings Limited was incorporated in accordance with the Cayman Islands Act on January 15, 2016. Its main business is investment holding. The Group has three subsidiaries in Hong Kong, China, Weida Healthcare Co., Ltd., China Inspection International Co., Ltd., and Avid (China) Co., Ltd. Each of the three subsidiaries has subsidiaries or branches in mainland China, and offices in major cities across the country. The company has nearly 550 employees, mainly engaged in R&D, production and sales of medical devices and consumables for in vitro diagnosis, and operates throughout mainland China and Hong Kong, China. Since the establishment of Weishida Medical Co., Ltd. in 1993, we have focused on the in vitro diagnosis business. After more than 20 years of development, we have now become a leading professional company in vitro diagnosis business in China, providing value-added products and services to the Chinese testing community.
No Data